editorial

As scientific output grows, the risk of a promising drug getting lost increases, but advances in artificial intelligence and machine learning may prevent that.

Take a look into the making of the DDN Dialogues podcast episode: From warhead to cancer-killer, the quest for more actinium-225.

Research misconduct poisons the well of scientific literature, but finding systemic ways to change the current “publish or perish” culture will help.

The best scientific presentations are not just about the science. The delivery matters too.

No one ever hopes to mess up an experiment, but sometimes what seems like a frustrating misstep actually sparks a discovery.

We should expand our definition of what it means to be a scientist to include all of the important roles that stem from this identity.  

A recent court case targeting the Food and Drug Administration’s regulatory authority sets a worrying precedent for the future of drug development.

Research safety programs should address not only immediate hazards, but daily laboratory activities that could cause adverse effects down the road.

In writing about new pain treatments that could benefit a family member, I was reminded of the real people behind every study and story.

As scientific conferences return to in person programming, we still need COVID-19 precautions.